Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

Jean-Pierre Bassand, Gabriele Accetta, Alan John Camm, Frank Cools, David A. Fitzmaurice, Keith A. A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Lorenzo G. Mantovani, Frank Misselwitz, Hugo ten Cate, Alexander G. G. Turpie, Freek W. A. Verheugt, Ajay K. Kakkar

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)2882-2889A
JournalEuropean Heart Journal
Volume37
Issue number38
DOIs
Publication statusPublished - 7 Oct 2016

Keywords

  • Atrial fibrillation
  • Anticoagulation
  • Stroke prevention
  • Stroke
  • Bleeding

Cite this

Bassand, J-P., Accetta, G., Camm, A. J., Cools, F., Fitzmaurice, D. A., Fox, K. A. A., Goldhaber, S. Z., Goto, S., Haas, S., Hacke, W., Kayani, G., Mantovani, L. G., Misselwitz, F., ten Cate, H., Turpie, A. G. G., Verheugt, F. W. A., & Kakkar, A. K. (2016). Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. European Heart Journal, 37(38), 2882-2889A. https://doi.org/10.1093/eurheartj/ehw233